 |
 Video: What is a Stock Split?
|
|
|
| GH Research is a holding company. Through its subsidiary, Co. is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. Co.'s initial focus is on developing its novel and proprietary 5-Methoxy-N,N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Co.'s portfolio includes GH001, Co.'s proprietary inhalable 5-MeO-DMT product candidate which is delivered via a vaporization device produced by a third party, and GH002, Co.'s proprietary injectable 5-MeO-DMT product candidate. According to our GH Research PLC stock split history records, GH Research PLC has had 0 splits. | |
|
GH Research PLC (GHRS) has 0 splits in our GH Research PLC stock split history database.
Looking at the GH Research PLC stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into GH Research PLC shares, starting with a $10,000 purchase of GHRS, presented on a split-history-adjusted basis factoring in the complete GH Research PLC stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/28/2021 |
|
| End date: |
05/03/2024 |
|
| Start price/share: |
$19.60 |
|
| End price/share: |
$11.68 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-40.41% |
|
| Average Annual Total Return: |
-16.61% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$5,959.76 |
|
| Years: |
2.85 |
|
|
|
|
|
